Valeriana jatamansi Constituent IVHD-valtrate As a Novel Therapeutic Agent to Human Ovarian Cancer: in vitro and in vivo Activities and Mechanisms

2013 ◽  
Vol 13 (4) ◽  
pp. 472-483 ◽  
Author(s):  
Xiaoguang Li ◽  
Tao Chen ◽  
Sheng Lin ◽  
Jing Zhao ◽  
Peizhan Chen ◽  
...  
2002 ◽  
Vol 86 (10) ◽  
pp. 1652-1657 ◽  
Author(s):  
R E Aird ◽  
J Cummings ◽  
A A Ritchie ◽  
M Muir ◽  
R E Morris ◽  
...  

2012 ◽  
Vol 12 (4) ◽  
pp. 336-346 ◽  
Author(s):  
Ellie S. M. Chu ◽  
Stephen C. W. Sze ◽  
Ho P. Cheung ◽  
Qing Liu ◽  
Tzi B. Ng ◽  
...  

PLoS ONE ◽  
2012 ◽  
Vol 7 (2) ◽  
pp. e32521 ◽  
Author(s):  
Abhay kumar Singh ◽  
Ratnakar Singh ◽  
Farhat Naz ◽  
Shyam Singh Chauhan ◽  
Amit Dinda ◽  
...  

2013 ◽  
Vol 29 (4) ◽  
pp. 1371-1378 ◽  
Author(s):  
BEI ZHANG ◽  
XUEYA WANG ◽  
FENGFENG CAI ◽  
WEIJIE CHEN ◽  
ULI LOESCH ◽  
...  

2007 ◽  
Vol 141 (2) ◽  
pp. 284-288 ◽  
Author(s):  
Sheng-Hua Chu ◽  
Hong Zhang ◽  
Yan-Bin Ma ◽  
Dong-Fu Feng ◽  
Zhi-An Zhu ◽  
...  

2020 ◽  
Vol 21 (21) ◽  
pp. 8169
Author(s):  
Demetra H. Hufnagel ◽  
Gabriella D. Cozzi ◽  
Marta A. Crispens ◽  
Alicia Beeghly-Fadiel

Platelets are critical components of a number of physiologic processes, including tissue remodeling after injury, wound healing, and maintenance of vascular integrity. Increasing evidence suggests that platelets may also play important roles in cancer. In ovarian cancer, thrombocytosis, both at the time of initial diagnosis and at recurrence, has been associated with poorer prognosis. This review describes current evidence for associations between thrombocytosis and ovarian cancer prognosis and discusses the clinical relevance of platelet count thresholds and timing of assessment. In addition, we discuss several mechanisms from in vitro, in vivo, and clinical studies that may underlie these associations and recommend potential approaches for novel therapeutic targets for this lethal disease.


2021 ◽  
Vol 8 (1) ◽  
pp. 141-155
Author(s):  
Enrique Ortega ◽  
Francisco J. Ballester ◽  
Alba Hernández-García ◽  
Samanta Hernández-García ◽  
M. Alejandra Guerrero-Rubio ◽  
...  

Novel Os(ii) arene complexes with a deprotonated ppy or ppy-CHO C^N ligand have been synthesized to selectively act on cancer cells as proteosynthesis inhibitors in vitro and exert antitumor activity in vivo in C. elegans models.


2018 ◽  
Vol 61 (11) ◽  
pp. 5009-5019 ◽  
Author(s):  
Betsy Marydasan ◽  
Bollapalli Madhuri ◽  
Shirisha Cherukommu ◽  
Jedy Jose ◽  
Mambattakkara Viji ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document